Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 1, 2013, Pages 105-113

  Colace, Thomas V ^a   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

glycoprotein Ib; hemodynamics; platelet; stenosis; von Willebrand Factor

Indexed keywords

4 [4 [4 (AMINOIMINOMETHYL)PHENYL] 1 PIPERAZINYL] 1 PIPERIDINEACETIC ACID; COLLAGEN; COLLAGEN TYPE 1; EDETIC ACID; GLYCOPROTEIN IB; VON WILLEBRAND FACTOR;

ARTERY PERFUSION; ARTICLE; BLOOD FLOW VELOCITY; EPIFLUORESCENCE MICROSCOPY; HUMAN; MALE; MICROFLUIDICS; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHEAR RATE; SURFACE PROPERTY; THROMBOCYTE AGGREGATION; THROMBOCYTE FREE PLASMA; VISCOMETRY;

BLOOD PLATELETS; CALCIUM; COLLAGEN TYPE I; HUMANS; MALE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROSCOPY, FLUORESCENCE; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; THROMBOSIS; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 84871743034     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300522     Document Type: Article

References (38)

1. Li MX, Beech-Brandt JJ, John LR, Hoskins PR, Easson WJ. Numerical analysis of pulsatile blood flow and vessel wall mechanics in different degrees of stenoses. J Biomech. 2007;40:3715-3724.
2. Bark DL Jr, Ku DN. Wall shear over high degree stenoses pertinent to atherothrombosis. J Biomech. 2010;43:2970-2977.
3. Banerjee RK, Back LH, Back MR, Cho YI. Physiological flow analysis in significant human coronary artery stenoses. Biorheology. 2003;40:451-476.
4. Schirmer CM, Malek AM. Patient based computational fluid dynamic characterization of carotid bifurcation stenosis before and after endovascular revascularization. J Neurointerv Surg. 2012;4:448-454.
5. Stroud JS, Berger SA, Saloner D. Numerical analysis of flow through a severely stenotic carotid artery bifurcation. J Biomech Eng. 2002;124:9-20.
6. Kim HJ, Vignon-Clementel IE, Coogan JS, Figueroa CA, Jansen KE, Taylor CA. Patient-specific modeling of blood flow and pressure in human coronary arteries. Ann Biomed Eng. 2010;38:3195-3209.
7. Long Q, Xu XY, Ramnarine KV, Hoskins P. Numerical investigation of physiologically realistic pulsatile flow through arterial stenosis. J Biomech. 2001;34:1229-1242.
8. Ojha M, Cobbold RS, Johnston KW, Hummel RL. Detailed visualization of pulsatile flow fields produced by modelled arterial stenoses. J Biomed Eng. 1990;12:463-469.
9. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282:2035-2042.
10. Savage B, Saldívar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289-297.
11. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 1995;270:23352-23361.
12. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB; Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4:2103-2114.
13. Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood. 2003;101:2637-2645.
14. Dayananda KM, Singh I, Mondal N, Neelamegham S. von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation. Blood. 2010;116:3990-3998.
15. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987;69:625-628.
16. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 1988;71:1366-1374.
17. Li F, Li CQ, Moake JL, López JA, McIntire LV. Shear stress-induced binding of large and unusually large von Willebrand factor to human platelet glycoprotein Ibalpha. Ann Biomed Eng. 2004;32:961-969.
18. Kumar RA, Moake JL, Nolasco L, Bergeron AL, Sun C, Dong JF, McIntire LV. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor. Biorheology. 2006;43:681-691.
19. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, Schneider MF. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci USA. 2007;104:7899-7903.
20. Steppich DM, Angerer JI, Sritharan K, Schneider SW, Thalhammer S, Wixforth A, Alexander-Katz A, Schneider MF. Relaxation of ultralarge VWF bundles in a microfluidic-AFM hybrid reactor. Biochem Biophys Res Commun. 2008;369:507-512.
21. Barg A, Ossig R, Goerge T, Schneider MF, Schillers H, Oberleithner H, Schneider SW. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network. Thromb Haemost. 2007;97:514-526.
22. Nesbitt WS, Westein E, Tovar-Lopez FJ, Tolouei E, Mitchell A, Fu J, Carberry J, Fouras A, Jackson SP. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 2009;15:665-673.
23. Yong AS, Pennings GJ, Chang M, Hamzah A, Chung T, Qi M, Brieger D, Behnia M, Krilis SA, Ng MK, Lowe HC, Kritharides L. Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood. 2011;117:11-20.
24. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-349.
25. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213.
26. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-684.
27. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science. 2009;324:1330-1334.
28. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood. 2006;108:1903-1910.
29. Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, López JA. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood. 2001;97:162-168.
30. Flamm MH, Colace TV, Chatterjee MS, Jing H, Zhou S, Jaeger D, Brass LF, Sinno T, Diamond SL. Multiscale prediction of patient-specific platelet function under flow. Blood. 2012;120:190-198.
31. Neeves KB, Maloney SF, Fong KP, Schmaier AA, Kahn ML, Brass LF, Diamond SL. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J Thromb Haemost. 2008;6:2193-2201.
32. Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol. 2012;32:1466-1476.
33. Anderson PJ, Kokame K, Sadler JE. Zinc and calcium ions cooperatively modulate ADAMTS13 activity. J Biol Chem. 2006;281:850-857.
34. Xu AJ, Springer TA. Calcium stabilizes the von Willebrand factor A2 domain by promoting refolding. Proc Natl Acad Sci USA. 2012;109:3742-3747.
35. Sing CE, Alexander-Katz A. Globule-stretch transitions of collapsed polymers in elongational flow fields. Macromolecules. 2010;43:3532-3541.
36. Sing CE, Alexander-Katz A. Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates. Biophys J. 2010;98:L35-L37.
37. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation. 2000;102:1290-1295.
38. Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, Jackson SP. A revised model of platelet aggregation. J Clin Invest. 2000;105:783-791.